Detalhe da pesquisa
1.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet;
403(10442): 2416-2425, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763153
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet;
403(10442): 2405-2415, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763154
3.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer;
151(3): 422-434, 2022 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35411939
4.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med;
377(4): 338-351, 2017 07 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28578639
5.
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.
BMC Cancer;
19(1): 947, 2019 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31615476
6.
Urinary, bowel and sexual health in older men from Northern Ireland.
BJU Int;
122(5): 845-857, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29489050
7.
FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases.
J Urol;
193(1): 325-30, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24933362
8.
Diethylstilboestrol (1 mg) in the management of castration-resistant prostate cancer.
Urol Int;
94(3): 307-12, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25342383
9.
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.
Res Sq;
2023 Feb 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36798177
10.
Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.
Eur Urol;
76(2): 228-237, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31060822
11.
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
Eur Urol;
76(6): 719-728, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31447077
12.
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Eur Urol Oncol;
1(6): 449-458, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31158087
13.
Do prostate cancer nomograms give accurate information when applied to European patients?
Scand J Urol;
49(1): 16-24, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24882277
14.
The use of acellular porcine collagen matrix to facilitate renal parenchymal closure during partial nephrectomy.
BJU Int;
96(7): 1142-3, 2005 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16225545